News
Sanders said during a news conference on Monday that the cancer was found when he went for a precautionary annual CT scan; he has a history of blood clots in his legs. Bladder cancer is more common in ...
Deion Sanders had bladder cancer. Here’s what to know about a disease that’s more common in men Bladder cancer is the 10th leading cause of cancer death in the United States.
Deion Sanders announced during a University of Colorado press conference on Monday that he had surgery to have his bladder removed after being diagnosed with cancer.
University of Colorado head football coach Deion Sanders had actress Karrueche Tran by his side as he underwent surgery to remove his bladder after doctors found a cancerous tumor in May.
Deion Sanders announces he battled bladder cancer and is now cancer-free after tumor removal surgery, while doctors share important warning signs to watch for.
Hall of Fame cornerback and Colorado coach Deion Sanders met with reporters on Monday to disclose his health issues. His doctors disclosed that Deion has bladder cancer, and that he underwent a full ...
University of Colorado football coach Deion Sanders announced he got a new bladder this week as part of his cancer treatment. Here's how doctors construct a new bladder from a patient's small ...
From dealing with a catheter to using adult diapers, University of Colorado head football coach Deion Sanders is willing to speak out about his cancer recovery.
The patient's new doctor performed a post-void residual (PVR) ultrasound and cystoscope, and determined his bladder was very ...
9d
Medical Device Network on MSNNatera’s Signatera test to be used in Phase III bladder cancer trial
The trial will assess if shorter radiation matches current outcomes in muscle-invasive bladder cancer, using Signatera for ...
3d
TipRanks on MSNenGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy
An update from enGene Holdings ( ($ENGN) ) is now available. enGene Holdings Inc. has achieved its target enrollment of 100 patients for the ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results